Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

March 19, 2021

Primary Completion Date

March 19, 2024

Study Completion Date

March 19, 2026

Conditions
Hematologic MalignancyStem Cell Transplant Complications
Interventions
DRUG

Azacitidine in Combination With Venetoclax

Azacitidine in combination with venetoclax

Trial Locations (1)

310000

RECRUITING

The first Affiliated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

collaborator

Zhejiang Provincial People's Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhejiang Chinese Medical University

OTHER

collaborator

Sir Run Run Shaw Hospital

OTHER

collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

Ningbo No. 1 Hospital

OTHER

collaborator

Yinzhou Hospital Affiliated to Medical School of Ningbo University

OTHER

collaborator

Jinhua Central Hospital

OTHER

collaborator

Taizhou Hospital

OTHER

collaborator

Union hospital of Fujian Medical University

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

lead

First Affiliated Hospital of Zhejiang University

OTHER